Homozygous α-Thalassemia Treated with Intrauterine Transfusions and Unrelated Donor Hematopoietic Cell Transplantation

Joanna S. Yi, Christopher L. Moertel, K. Scott Baker

Research output: Contribution to journalArticle

31 Scopus citations


Recently, intrauterine transfusions and hematopoietic cell transplantation (HCT) have changed homozygous alpha-thalassemia from a frequently fatal disease to a potentially survivable condition. We present a patient with Hemoglobin Bart's disease who was cured after failing to engraft with 1 unrelated HCT, but engrafting after a second unrelated donor HCT.

Original languageEnglish (US)
Pages (from-to)766-768
Number of pages3
JournalJournal of Pediatrics
Issue number5
StatePublished - May 1 2009


Cite this